PER 2.41% 8.1¢ percheron therapeutics limited

Clean insights and information easily found, page-67

  1. 13,112 Posts.
    lightbulb Created with Sketch. 1369
    SRP 901
    Fda passed it
    they then had to wait for a larger study
    Both trials missed their endpoints

    if endpoints don’t matter
    Why is the FDA making Per repeat a trial where Per successfully produced the PUL2.0 endpoints?
    Wasting time imo when boys are dying waiting Per to repeat.

    Improvements that the parents observed.. no science there.




 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.002(2.41%)
Mkt cap ! $73.02M
Open High Low Value Volume
8.1¢ 8.2¢ 8.0¢ $39.27K 485.4K

Buyers (Bids)

No. Vol. Price($)
1 365000 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 57142 1
View Market Depth
Last trade - 14.51pm 11/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.